Latest Medical statistics Stories
Aspire IRB and Midlands IRB become part of the WCG family, further expanding its geographic and program reach PRINCETON, N.J., June 16, 2014 /PRNewswire/ -- The WIRB-Copernicus Group
PHILADELPHIA, June 16, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc.
SANTA ROSA, Calif., June 4, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics
VIENNA, June 4, 2014 /PRNewswire/ -- AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug
Results of CISCRP Study Provide New Insights Into How to Engage the Public and Patients PRINCETON, N.J., June 2, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment
SYDNEY and BEDMINSTER, N.J., May 27, 2014 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has
SAN FRANCISCO, May 22, 2014 /PRNewswire/ -- PULSE enables highly customized IRT trial design while maintaining endpoint's signature 30-Day delivery timeline
SAN FRANCISCO, May 19, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biopharmaceutical company developing novel pain and cancer therapeutics, announced that Ivan Gergel, M.D., will
Collaboration Will Ensure Local Monitoring and Centralized Clinical Research Technology for Sponsors of Multinational Clinical Trials Irvine, CA (PRWEB) May
Major Pharmaceutical Companies Serving in ADDPLAN DF Consortium Providing Early Feedback Dublin, Ireland (PRWEB) May 13, 2014 ICON plc (NASDAQ: ICLR),
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.